Episode Details
Back to EpisodesThe Health Marketing Daily | GLP-1 drugs put $73B in global | Little Spoon Takes Its 'Feeding Platform' | Scientists find the whole grain 'sweet
Published 1 week, 3 days ago
Description
The Health Marketing Daily — September 23, 2026
In this episode:
• A new report quantifies how GLP-1 drug adoption is actively reshaping food spending at scale — with direct implications for how functional and wellness food brands should reposition their portfolios.
• Little Spoon's pivot from baby food into kids' vitamins shows how children's nutrition brands are evolving into full supplement platforms — a model European brands should be watching closely.
• A landmark review of 87 clinical trials identifies a specific daily serving range where whole grain consumption meaningfully benefits cardiovascular health — giving functional food brands a precise, evidence-based claim to build around.
• New research showing over 93,000 visible appearances of 'unhealthy' food brand placements during the 2026 FIFA World Cup is set to intensify EU regulatory pressure on food marketing — and hands wellness brands a powerful counter-narrative.
Hosted by Marco & Klara. New episode every weekday.
Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health